Cancer Survivorship Care in Bavaria: General Practitioners’ Perspectives and a Regional Capacity Analysis
DMW - Deutsche Medizinische Wochenschrift · 01.10.2026 · 151 (21) · e57-e66
DOI: 10.1055/a-2937-2937 ↗Kurz gefasst
Fachartikel in der Zeitschrift DMW - Deutsche Medizinische Wochenschrift, erschienen am 01.10.2026. Verfasst von Laura Oestreich und 4 weiteren Autor:innen. Beteiligte Einrichtung: LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Department of Medicine III, Germany, Munich. Hauptthemen laut MEDLINE: General Practitioners, Cancer Survivors, Attitude of Health Personnel, Survivorship. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The rising number of cancer survivors in Germany increases the need for long-term, coordinated cross-sectoral care. General practitioners (GPs) play a key role, yet evidence on regional structures and GPs’ perspectives is limited. This study examines cancer survivorship care in Bavaria by combining a regional capacity analysis with a statewide GP survey. A mixed-methods study was conducted in Bavaria, combining a regional structural analysis of physician availability and projected survivorship care demand with a statewide anonymous quantitative online GP survey on care experiences, collaboration, digital tools, training needs, vaccination practices, and reimbursement. In 2024, 9553 Bavarian GPs cared for approximately 380000 cancer survivors, with 17% living in areas of GP undersupply. Northern and Eastern Bavaria showed particularly high patient loads and projected shortages. Among 574 surveyed GPs, 72.7% perceived survivorship care as challenging. Key barriers included insufficient cross-sectoral collaboration (76.9%), limited knowledge of co-treating colleagues’ activities (72.6%), incomplete treatment information (31.7%), and inadequate reimbursement (95.2%). While most GPs (71.5%) considered the electronic patient record (ePA) promising, only 56.9% used KIM at least occasionally. 73.1% expressed interest in dedicated training and guidance, particularly regarding vaccination responsibilities and timing (64.1%). GPs in Bavaria face increasing structural and organizational challenges due to rising survivor numbers and regional workforce shortages. Improved information exchange, strengthened cross-sectoral collaboration, consistent digital communication, targeted GP training, and continuous regional monitoring, are essential to ensure sustainable, high-quality survivorship care across Germany.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Department of Medicine III, Germany, Munich.
- Bayerischer Hausärzteverband, Germany, Munich.
- Bavarian Cancer Research Center (BZKF), Germany, Munich.
- German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and LMU University Hospital, Germany, Munich.
ORCID-Profile: Laura Oestreich
Zitieren
APA
Oestreich, L., Schelling, J., Schoenberg, M., von Bergwelt-Baildon, M., & Berger-Thürmel, K. (2026). Cancer Survivorship Care in Bavaria: General Practitioners’ Perspectives and a Regional Capacity Analysis. DMW - Deutsche Medizinische Wochenschrift, 151(21), e57-e66. https://doi.org/10.1055/a-2937-2937
Vancouver
Oestreich L, Schelling J, Schoenberg M, von Bergwelt-Baildon M, Berger-Thürmel K. Cancer Survivorship Care in Bavaria: General Practitioners’ Perspectives and a Regional Capacity Analysis. DMW - Deutsche Medizinische Wochenschrift. 2026;151(21):e57-e66. doi:10.1055/a-2937-2937
BibTeX
@article{Oestreich2026,
author = {Oestreich, Laura and Schelling, Jörg and Schoenberg, Michael and von Bergwelt-Baildon, Michael and Berger-Thürmel, Karin},
title = {Cancer Survivorship Care in Bavaria: General Practitioners’ Perspectives and a Regional Capacity Analysis},
journal = {DMW - Deutsche Medizinische Wochenschrift},
year = {2026},
volume = {151},
number = {21},
pages = {e57--e66},
doi = {10.1055/a-2937-2937}
}
EUVIMED